Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

Association Between Serum Uric Acid Level and Metabolic Syndrome

  • Lee, Ju-Mi (Department of Preventive Medicine, Yonsei University College of Medicine) ;
  • Kim, Hyeon-Chang (Department of Preventive Medicine, Yonsei University College of Medicine) ;
  • Cho, Hye-Min (Department of Preventive Medicine, Yonsei University College of Medicine) ;
  • Oh, Sun-Min (Department of Preventive Medicine, Yonsei University College of Medicine) ;
  • Choi, Dong-Phil (Department of Preventive Medicine, Yonsei University College of Medicine) ;
  • Suh, Il (Department of Preventive Medicine, Yonsei University College of Medicine)
  • Received : 2011.08.17
  • Accepted : 2012.01.20
  • Published : 2012.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: Serum uric acid levels have been reported to be associated with a variety of cardiovascular conditions. However, the direct association between uric acid levels and metabolic syndrome remains controversial. Thus, we evaluated the association of serum uric acid levels and metabolic syndrome in a community-based cohort study in Korea. Methods: We performed cross-sectional analysis of baseline data of 889 males and 1491 females (aged 38 to 87) who participated in baseline examinations of the Korean Genome and Epidemiology Study: Kanghwa study. Blood samples were collected after at least an 8 hour fast. Uric acid quartiles were defined as follows: <4.8, 4.8-<5.6, 5.6-<6.5, ${\geq}6.5$ mg/dL in males; and <3.8, 3.8- <4.3, 4.3 - <5.1, ${\geq}5.1$ mg/dL in females. Metabolic syndrome was defined by the National Cholesterol Education Program Adult Treatment Panel III Criteria with adjusted waist circumference cutoffs (90 cm for males; 80 cm for females). The association between serum uric acid quartiles and metabolic syndrome was assessed using multivariate logistic regression. Results: The odds ratio for having metabolic syndrome in the highest versus lowest quartiles of serum uric acid levels was 2.67 (95% confidence interval [CI], 1.60 to 4.46) in males and 2.14 (95% CI, 1.50 to 3.05) in females after adjusting for age, smoking, alcohol intake, body mass index, total cholesterol, HbA1c, albumin, ${\gamma}$-glutamyltransferase, blood urea nitrogen, and log C-reactive protein. The number of metabolic abnormalities also increased gradually with increasing serum uric acid levels (adjusted p for trend < 0.001 in both sexes). Conclusions: Higher serum uric acid levels are positively associated with the presence of metabolic syndrome in Korean males and females.

Keywords

References

  1. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008;359(17):1811-1821.
  2. Kim HC, Kang DR, Choi KS, Nam CM, Thomas GN, Suh I. Spousal concordance of metabolic syndrome in 3141 Korean couples: a nationwide survey. Ann Epidemiol 2006;16(4):292-298.
  3. Oh HJ, Moon SH, Lee JW, Hyun HY, Lee DC, Lee HR. Relationship between serum uric acid and metabolic syndrome. J Korean Acad Fam Med 2006;27(9):699-705 (Korean).
  4. Lim S, Park KS, Lee HK, Cho SI; Korean National Health and Nutrition Examination Surveys. Changes in the characteristics of metabolic syndrome in Korea over the period 1998-2001 as determined by Korean National Health and Nutrition Examination Surveys. Diabetes Care 2005;28(7):1810-1812.
  5. Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won Yoon J, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 2011; 34(6):1323-1328.
  6. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 2005;25(5):1038-1044.
  7. Lim JH, Kim YK, Kim YS, Na SH, Rhee MY, Lee MM. Relationship between serum uric acid levels, metabolic syndrome, and arterial stiffness in Korean. Korean Circ J 2010;40(7):314-320.
  8. Lin SD, Tsai DH, Hsu SR. Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc 2006;69(11):512-516.
  9. Kim SK, Park HA, Nam OY, Beck SH, Whang DH, Hwang UK, et al. Risk of the metabolic syndrome according to the level of the uric acid. J Korean Acad Fam Med 2007;28(6): 428-435 (Korean).
  10. Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007;120(5): 442-447.
  11. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Sari I, et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 2006;19(10):1055-1062.
  12. Longo DL, Kasper DL, Braunwald E, Fauci AS, Harrison TR, Hauser SL, et al. Harrison's principles of internal medicine. 17th ed. New York: McGraw-Hill Medical; 2008, p. 2447.
  13. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112(17):2735-2752.
  14. Lee JY, Ahn SV, Choi DP, Suh M, Kim HC, Kim YS, et al. Association between hypertension and pulmonary function in rural adults in Korea. J Prev Med Public Health 2009;42(1):21-28 (Korean).
  15. Oh SM, Kim HC, Ahn SV, Chi HJ, Suh I. Association between meat consumption and carotid intima-media thickness in Korean adults with metabolic syndrome. J Prev Med Public Health 2010;43(6):486-495.
  16. Suh M, Lee JY, Ahn SV, Kim HC, Suh I. C-reactive protein and carotid intima-media thickness in a population of middle-aged Koreans. J Prev Med Public Health 2009; 42(1):29-34 (Korean).
  17. Kang DH. Potential role of uric Acid as a risk factor for cardiovascular disease. Korean J Intern Med 2010;25(1): 18-20.
  18. Wikipedia. Uric acid [cited 2011 Mar 4]. Available from: http://en.wikipedia.org/wiki/Uric_acid.
  19. Glynn RJ, Campion EW, Silbert JE. Trends in serum uric acid levels 1961-1980. Arthritis Rheum 1983;26(1):87-93.
  20. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005;67(5):1739-1742.
  21. Cook S, Hugli O, Egli M, Vollenweider P, Burcelin R, Nicod P, et al. Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med Wkly 2003;133(25-26):360-363.
  22. Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M, et al. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 2004;94(7):932-935.
  23. Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007;293(2):C584-C596.
  24. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114(12):1752-1761.
  25. Cheung KJ, Tzameli I, Pissios P, Rovira I, Gavrilova O, Ohtsubo T, et al. Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity. Cell Metab 2007; 5(2):115-128.
  26. Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension 2003;42(3):247-252.
  27. Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004; 164(14):1546-1551.
  28. Nakagawa T, Tuttle KR, Short RA, Johnson RJ. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 2005;1(2):80-86.
  29. Cook DG, Shaper AG, Thelle DS, Whitehead TP. Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J 1986;62(733):1001-1006.

Cited by

  1. The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome vol.110, pp.11, 2012, https://doi.org/10.1160/th13-06-0499
  2. Risk factors for incident hyperuricemia during mid-adulthood in African American and White men and women enrolled in the ARIC cohort study vol.14, pp.None, 2012, https://doi.org/10.1186/1471-2474-14-347
  3. Metabolic syndrome, diabetes, and hyperuricemia vol.25, pp.2, 2012, https://doi.org/10.1097/bor.0b013e32835d951e
  4. Hyperuricaemia : more than just a cause of gout? vol.14, pp.6, 2012, https://doi.org/10.2459/jcm.0b013e3283595adc
  5. Association between Serum 25-Hydroxyvitamin D Level and Insulin Resistance in a Rural Population vol.55, pp.4, 2012, https://doi.org/10.3349/ymj.2014.55.4.1036
  6. A possible role of serum uric acid as a marker of metabolic syndrome vol.44, pp.a12, 2012, https://doi.org/10.1111/imj.12588
  7. Antioxidative phytochemicals from Rhododendron oldhamii Maxim. leaf extracts reduce serum uric acid levels in potassium oxonate-induced hyperuricemic mice vol.15, pp.None, 2015, https://doi.org/10.1186/s12906-015-0950-7
  8. Prevalence of metabolic syndrome and pre-metabolic syndrome in health professionals: LATINMETS Brazil study vol.7, pp.None, 2012, https://doi.org/10.1186/s13098-015-0003-x
  9. Mangiferin Inhibits Renal Urate Reabsorption by Modulating Urate Transporters in Experimental Hyperuricemia vol.38, pp.10, 2015, https://doi.org/10.1248/bpb.b15-00402
  10. Serum Uric Acid and Subsequent Cognitive Performance in Patients with Pre-Existing Cardiovascular Disease vol.10, pp.3, 2012, https://doi.org/10.1371/journal.pone.0120862
  11. Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance vol.14, pp.2, 2012, https://doi.org/10.1089/met.2015.0113
  12. Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease vol.20, pp.3, 2012, https://doi.org/10.1517/14728222.2016.1096930
  13. Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study vol.16, pp.None, 2012, https://doi.org/10.1186/s12872-016-0265-8
  14. Association of Education, Health Behaviors, Concerns, and Knowledge with Metabolic Syndrome among Urban Elderly in One Medical Center in Taiwan vol.11, pp.3, 2012, https://doi.org/10.1016/j.ijge.2016.09.006
  15. Screening of effective xanthine oxidase inhibitors in dietary anthocyanins from purple sweet potato (Ipomoea batatas L. Cultivar Eshu No.8) and deciphering of the underlying mechanisms in vitro vol.36, pp.None, 2012, https://doi.org/10.1016/j.jff.2017.06.048
  16. Production Inhibition and Excretion Promotion of Urate by Fucoidan from Laminaria japonica in Adenine-Induced Hyperuricemic Mice vol.16, pp.12, 2018, https://doi.org/10.3390/md16120472
  17. The Association Between Metabolic Syndrome and Serum Concentrations of Micronutrients, Inflammation, and Oxidative Stress Outside of the Clinical Reference Ranges: A Cross-Sectional Study vol.17, pp.1, 2012, https://doi.org/10.1089/met.2018.0080
  18. Uric Acid Levels Correlate with Sensory Nerve Function in Healthy Subjects vol.46, pp.3, 2019, https://doi.org/10.1017/cjn.2019.9
  19. Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016-2019) vol.29, pp.11, 2012, https://doi.org/10.1080/13543776.2019.1676727
  20. Associations of Serum Uric Acid with Endogenous Cholesterol Synthesis Indices in Men with High Cardiometabolic Risk vol.18, pp.4, 2012, https://doi.org/10.1089/met.2019.0105
  21. The association of serum uric acid with metabolic syndrome and its components-From a single‐clinical centre in China vol.75, pp.4, 2012, https://doi.org/10.1111/ijcp.13845
  22. 직업군별 좌식시간과 고위험음주에 따른 고요산혈증의 유병률과 위험도에 관한 연구 vol.11, pp.7, 2012, https://doi.org/10.22156/cs4smb.2021.11.07.278
  23. Can biomarkers be used to improve diagnosis and prediction of metabolic syndrome in childhood cancer survivors? A systematic review vol.22, pp.11, 2021, https://doi.org/10.1111/obr.13312